Jianchun Duan , Wenfeng Fang , Hairong Xu , Jinliang Wang , Yuan Chen , Yi Ding , Xiaorong Dong , Yun Fan , Beili Gao , Jie Hu , Yan Huang , Cheng Huang , Dingzhi Huang , Wenhua Liang , Lizhu Lin , Hui Liu , Zhiyong Ma , Meiqi Shi , Yong Song , Chuanhao Tang , Jie Wang
{"title":"中国肺癌骨转移诊治专家共识(2022版)","authors":"Jianchun Duan , Wenfeng Fang , Hairong Xu , Jinliang Wang , Yuan Chen , Yi Ding , Xiaorong Dong , Yun Fan , Beili Gao , Jie Hu , Yan Huang , Cheng Huang , Dingzhi Huang , Wenhua Liang , Lizhu Lin , Hui Liu , Zhiyong Ma , Meiqi Shi , Yong Song , Chuanhao Tang , Jie Wang","doi":"10.1016/j.jncc.2023.08.004","DOIUrl":null,"url":null,"abstract":"<div><p>Lung cancer is the leading cause of cancer-related deaths worldwide. Bone is a common metastatic site of lung cancer, about 50% of bone metastatic patients will experience skeletal related events (SREs). SREs not only seriously impact the quality of life of patients, but also shorten their survival time. The treatment of bone metastasis requires multi-disciplinary therapy (MDT) and development of individualized treatment plan. In order to standardize the diagnosis and treatment of bone metastasis in lung cancer, the expert group of the MDT Committee of the Chinese Medical Doctor Association has developed the expert consensus on the diagnosis and treatment of lung cancer bone metastasis.</p></div>","PeriodicalId":73987,"journal":{"name":"Journal of the National Cancer Center","volume":"3 4","pages":"Pages 256-265"},"PeriodicalIF":7.6000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667005423000492/pdfft?md5=665a7ce34e38970b91bbf5d9106b2523&pid=1-s2.0-S2667005423000492-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)\",\"authors\":\"Jianchun Duan , Wenfeng Fang , Hairong Xu , Jinliang Wang , Yuan Chen , Yi Ding , Xiaorong Dong , Yun Fan , Beili Gao , Jie Hu , Yan Huang , Cheng Huang , Dingzhi Huang , Wenhua Liang , Lizhu Lin , Hui Liu , Zhiyong Ma , Meiqi Shi , Yong Song , Chuanhao Tang , Jie Wang\",\"doi\":\"10.1016/j.jncc.2023.08.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Lung cancer is the leading cause of cancer-related deaths worldwide. Bone is a common metastatic site of lung cancer, about 50% of bone metastatic patients will experience skeletal related events (SREs). SREs not only seriously impact the quality of life of patients, but also shorten their survival time. The treatment of bone metastasis requires multi-disciplinary therapy (MDT) and development of individualized treatment plan. In order to standardize the diagnosis and treatment of bone metastasis in lung cancer, the expert group of the MDT Committee of the Chinese Medical Doctor Association has developed the expert consensus on the diagnosis and treatment of lung cancer bone metastasis.</p></div>\",\"PeriodicalId\":73987,\"journal\":{\"name\":\"Journal of the National Cancer Center\",\"volume\":\"3 4\",\"pages\":\"Pages 256-265\"},\"PeriodicalIF\":7.6000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2667005423000492/pdfft?md5=665a7ce34e38970b91bbf5d9106b2523&pid=1-s2.0-S2667005423000492-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the National Cancer Center\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667005423000492\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the National Cancer Center","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667005423000492","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)
Lung cancer is the leading cause of cancer-related deaths worldwide. Bone is a common metastatic site of lung cancer, about 50% of bone metastatic patients will experience skeletal related events (SREs). SREs not only seriously impact the quality of life of patients, but also shorten their survival time. The treatment of bone metastasis requires multi-disciplinary therapy (MDT) and development of individualized treatment plan. In order to standardize the diagnosis and treatment of bone metastasis in lung cancer, the expert group of the MDT Committee of the Chinese Medical Doctor Association has developed the expert consensus on the diagnosis and treatment of lung cancer bone metastasis.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
